
Recent media releases
25-Apr-2012
To sustain gains and save more lives, Novartis continues to invest heavily in malaria control
13-Mar-2012
Novartis ‘Making Health a Lifestyle’ program wins DOH advocacy award
31-Jan-2012
Education, policies, R&D identified as priority areas in strengthening country’s leprosy control program
31-Jan-2012
Novartis joins with key stakeholders in holistic approach towards leprosy elimination
31-Jan-2012
Novartis Foundation for Sustainable Development, DOH to hold country’s first leprosy stakeholders symposium
25-Jan-2012
Novartis joins with key stakeholders in holistic approach towards leprosy elimination
18-Jan-2012
Novartis Foundation for Sustainable Development, DOH to hold country’s first leprosy stakeholders symposium
Influenza A(H1N1) information center ›
At Novartis, we are making good progress in our efforts to rapidly produce and commercialize a vaccine against the H1N1 virus.

Patient Stories ›
Healthcare solutions provided by Novartis include innovative medicines, high-quality low-cost generic drugs, disease-preventing vaccines and diagnostic tools, and consumer health products. Read stories of actual patients whose lives have improved with Novartis.